Jonathan Drachman
2019 - Aquinox Pharmaceuticals
In 2019, Jonathan Drachman earned a total compensation of $3.8M as Chief Executive Officer at Aquinox Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $240,625 |
|---|---|
| Option Awards | $3,445,109 |
| Salary | $137,304 |
| Total | $3,823,038 |
Drachman received $3.4M in option awards, accounting for 90% of the total pay in 2019.
Drachman also received $240.6K in non-equity incentive plan and $137.3K in salary.
Rankings
In 2019, Jonathan Drachman's compensation ranked 3,133rd out of 13,971 executives tracked by ExecPay. In other words, Drachman earned more than 77.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,133 out of 13,971 | 78th |
Division Manufacturing | 1,132 out of 5,701 | 80th |
Major group Chemicals And Allied Products | 383 out of 2,200 | 83rd |
Industry group Drugs | 314 out of 1,886 | 83rd |
Industry Pharmaceutical Preparations | 231 out of 1,398 | 84th |
Source: SEC filing on March 24, 2020.
Drachman's colleagues
We found two more compensation records of executives who worked with Jonathan Drachman at Aquinox Pharmaceuticals in 2019.